Gyder Surgical Announces 510(k) FDA clearance for the GYDER® Hip System, the World’s First Commercially Available Pin-less and Image-less Solution for Accurate Positioning of the Acetabular Cup during Anterior Hip Arthroplasty
MULGRAVE, Australia & PALO ALTO, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — Gyder Surgical, a MedTech company specializing in intuitive, orthopaedic navigation solutions, today announced the 510(k) FDA clearance for the GYDER® Hip System, the world’s first commercially available non-invasive (pin-less) and image-less solution for the accurate positioning of the acetabular cup during Anterior Hip Arthroplasty. The FDA’s clearance decision is the second significant regulatory milestone for the GYDER® Hip System, which received Australia’s TGA regulatory approval previously. Surgical cases have already been successfully performed in Australia and India.
